NASDAQ:BKYI BIO-key International (BKYI) Stock Price, News & Analysis $2.87 -0.04 (-1.37%) As of 01:06 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsOwnershipSEC Filings About BIO-key International Stock (NASDAQ:BKYI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BIO-key International alerts:Sign Up Key Stats Today's Range$2.71▼$3.5550-Day Range$1.65▼$4.1752-Week Range$1.55▼$19.70Volume877,515 shsAverage Volume1.45 million shsMarket Capitalization$4.12 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview BIO-key International, Inc. (NASDAQ: BKYI) develops biometric identity and access-management solutions. Its technology enables organizations to authenticate users through fingerprints and other biometric credentials, helping replace or supplement passwords while supporting secure access to applications, networks and devices. The company’s offerings include biometric readers and software, as well as identity and access-management platforms such as PortalGuard and WEB-key. These products are designed to support multifactor authentication, single sign-on, password management and identity verification across on-premises and cloud-based environments. BIO-key serves businesses, government agencies, educational institutions and other organizations that require secure user authentication. The company was founded in 1999 and is headquartered in New Jersey. Its solutions are marketed primarily in North America, with availability through technology partners and resellers in additional markets.AI Generated. May Contain Errors. Read More BIO-key International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreBKYI MarketRank™: 0.983735571875 of 5 starsBIO-key International scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.2 / 5Analyst RatingReduce Consensus RatingBIO-key International has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageBIO-key International has only been the subject of 2 research reports in the past 90 days.Read more about BIO-key International's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for BIO-key International are expected to grow in the coming year, from ($1.62) to $0.22 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BIO-key International is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BIO-key International is -0.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBIO-key International has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about BIO-key International's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted72.18% of the float of BIO-key International has been sold short.Short Interest Ratio / Days to CoverBIO-key International has a short interest ratio ("days to cover") of 0.06, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BIO-key International has recently increased by 14,917.03%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBIO-key International does not currently pay a dividend.Dividend GrowthBIO-key International does not have a long track record of dividend growth. News and Social Media3.2 / 5News Sentiment0.16 News SentimentBIO-key International has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Technology companies.News Coverage This WeekMarketBeat has tracked 9 news articles for BIO-key International this week, compared to 3 articles on an average week.Search Interest6 people have searched for BKYI on MarketBeat in the last 30 days. MarketBeat Follows1 people have added BIO-key International to their MarketBeat watchlist in the last 30 days. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BIO-key International insiders have not sold or bought any company stock.Percentage Held by Insiders4.00% of the stock of BIO-key International is held by insiders.Percentage Held by Institutions26.51% of the stock of BIO-key International is held by institutions.Read more about BIO-key International's insider trading history. Receive BKYI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BKYI Stock News HeadlinesBIO-key International, Inc. Announces Management ChangesOctober 13 at 2:07 PM | marketscreener.comMBIO-key Appoints Stephen Morrow President of PortalGuard to Advance IAM Platform GrowthOctober 13 at 2:07 PM | finance.yahoo.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.October 15 at 1:00 AM | Altimetry (Ad)BIO-key International, Inc. Adds New Middle East Government Security Agency Customer, Expanding Regional FootprintOctober 13 at 9:06 AM | marketscreener.comMWhy is BIO-key International stock surging Tuesday?October 13 at 9:06 AM | msn.comBIO-key Names Cybersecurity Veteran Stephen Morrow President of PortalGuard to Drive Accelerated Adoption of its Innovative IAM SolutionOctober 13 at 8:29 AM | globenewswire.comBIO-key Adds New Middle East Government Security Agency Customer, Expanding Regional FootprintOctober 13 at 4:01 AM | globenewswire.comBIO-key International (NASDAQ:BKYI) versus Bitfarms (NASDAQ:BITF) Financial ComparisonOctober 11, 2026 | americanbankingnews.comSee More Headlines BKYI Stock Analysis - Frequently Asked Questions How have BKYI shares performed this year? BIO-key International's stock was trading at $5.3910 on January 1st, 2026. Since then, BKYI shares have decreased by 40.6% and is now trading at $3.20. How were BIO-key International's earnings last quarter? BIO-key International Inc. (NASDAQ:BKYI) announced its quarterly earnings results on Thursday, August, 13th. The technology company reported ($0.56) earnings per share for the quarter, beating analysts' consensus estimates of ($0.82) by $0.26. The technology company earned $1.92 million during the quarter, compared to analysts' expectations of $1.80 million. BIO-key International had a negative net margin of 50.01% and a negative trailing twelve-month return on equity of 67.31%. Read the conference call transcript. When did BIO-key International's stock split? BIO-key International's stock reverse split on the morning of Thursday, December 21st 2023.The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. How do I buy shares of BIO-key International? Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BIO-key International own? Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include Tesla (TSLA), NIO (NIO), Nokia (NOK), T2 Biosystems (TTOO), AYRO (AYRO), NVIDIA (NVDA) and Plug Power (PLUG). Company Calendar Last Earnings8/13/2026Today10/15/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (18m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 BKYI's financial health is in the Red zone, according to TradeSmith. BKYI has been in this zone for over 18 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTechnology Industry Software Sub-IndustrySystems Software Current SymbolNASDAQ:BKYI CIK1019034 Webwww.bio-key.com Phone(732) 359-1100Fax732-359-1101Employees42Year Founded1993Profitability EPS (Trailing Twelve Months)($4.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.16 million Net Margins-50.01% Pretax Margin-87.79% Return on Equity-67.31% Return on Assets-40.28% Debt Debt-to-Equity RatioN/A Current Ratio1.26 Quick Ratio1.14 Sales & Book Value Annual Sales$6.70 million Price / Sales0.62 Cash FlowN/A Price / Cash FlowN/A Book Value$4.71 per share Price / Book0.62Miscellaneous Outstanding Shares1,436,000Free Float1,379,000Market Cap$4.19 million OptionableNo Data Beta0.50 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:BKYI) was last updated on 10/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIO-key International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIO-key International With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
